| Titolo |
Pubblicato in |
Anno |
| IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2025 |
| Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study |
DIABETES, OBESITY AND METABOLISM |
2024 |
| Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
2024 |
| Obesity in type 1 diabetes: an overlooked immune-metabolic issue |
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM |
2024 |
| No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study |
CLINICAL THERAPEUTICS |
2024 |
| Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2024 |
| Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2024 |
| Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) |
THE LANCET DIABETES & ENDOCRINOLOGY |
2024 |
| Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2023 |
| Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials |
DIABETES, OBESITY AND METABOLISM |
2023 |
| Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy |
JOURNAL OF CLINICAL MEDICINE |
2023 |
| Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study |
DIABETES, OBESITY AND METABOLISM |
2023 |
| Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2023 |
| Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication |
FRONTIERS IN ENDOCRINOLOGY |
2022 |
| Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status |
THE AMERICAN JOURNAL OF CARDIOLOGY |
2022 |
| Development of a clinical risk score to predict death in patients with COVID-19 |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2022 |
| C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective |
DIABETES, OBESITY AND METABOLISM |
2022 |
